PP
NVS icon

PDT Partners’s Novartis NVS Stock Holding History

PDT Partners’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-45,348
Closed -$3.73M – 772
2015
Q3 		$3.73M Sell
45,348
-28,868
-39% -$2.57M 0.08% 286
2015
Q2 		$6.54M Sell
74,216
-38,536
-34% -$3.54M 0.17% 136
2015
Q1 		$9.96M Buy
112,752
+49,553
+78% +$4.4M 0.25% 94
2014
Q4 		$5.25M Sell
63,199
-387,029
-86% -$32.1M 0.5% 43
2014
Q3 		$38M Buy
+450,228
New +$36.4M 0.96% 6
2014
Q1 		– Sell
-234,325
Closed -$16.9M – 1344
2013
Q4 		$16.9M Buy
+234,325
New +$16.3M 2.03% 3
2013
Q3 		– Sell
-13,995
Closed -$887K – 1647
2013
Q2 		$887K Buy
+13,995
New +$911K 0.02% 860

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

PDT Partners's NVS Position: Q4 2015 in Review

PDT Partners sold out of Novartis (NVS) in Q4 2015, closing a stake of 45,348 shares — an estimated $3.73M sold.

PDT Partners first reported a position in NVS in Q2 2013 and held it in 7 quarters. The position peaked at $38M in Q3 2014. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

  • PDT Partners reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
  • PDT Partners sold 45,348 Novartis shares in Q4 2015, an estimated $3.73M.
  • PDT Partners first reported a position in Novartis in Q2 2013 and held it in 7 quarters.
  • PDT Partners's Novartis position peaked at $38M in Q3 2014.
  • 927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on PDT Partners's 13F filing for Q4 2015, filed 16 Feb 2016.